Hydration and health

Analysis in Nutrition Research: Principles of Statistical Methodology and Interpretation of the Results

Volumn , Issue , 2018, Pages 299-319

  Seal, Adam D ^a,b   Suh, Hyun Gyu ^a,b   Jansen, Lisa T ^a   Summers, LynnDee G ^a   Kavouras, Stavros A ^b  

^a UNIVERSITY OF ARKANSAS   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Bladder cancer; Cardiovascular health; Cognition; Dehydration; Diabetes; Fluid balance; Kidney health; Obesity; Oxidative stress; Underhydration

Indexed keywords

EID: 85059684026     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-814556-2.00011-7     Document Type: Chapter

References (131)

1. Kenney E.L., Long M.W., Cradock A.L., Gortmaker S.L. Prevalence of inadequate hydration among US children and disparities by gender and race/ethnicity: national health and nutrition examination survey, 2009-2012. Am J Public Health 2015, 105(8):e113-e118.
2. Gibson S., Shirreffs S.M. Beverage consumption habits "24/7" among British adults: association with total water intake and energy intake. Nutr J 2013, 12:9.
3. Hahn R.G., Waldreus N. An aggregate urine analysis tool to detect acute dehydration. Int J Sport Nutr Exerc Metab 2013, 23(4):303-311.
4. Armstrong L.E., Johnson E.C., McKenzie A.L., Munoz C.X. Interpreting common hydration biomarkers on the basis of solute and water excretion. Eur J Clin Nutr 2013, 67(3):249-253.
5. Oppliger R.A., Magnes S.A., Popowski L.A., Gisolfi C.V. Accuracy of urine specific gravity and osmolality as indicators of hydration status. Int J Sport Nutr Exerc Metab 2005, 15(3):236-251.
6. Armstrong L.E. Assessing hydration status: the elusive gold standard. J Am Coll Nutr 2007, 26(5 Suppl.):575S-584S.
7. Armstrong L.E., Kavouras S.A., Walsh N.P., Roberts W.O. Diagnosing dehydration? Blend evidence with clinical observations. Curr Opin Clin Nutr Metab Care 2016, 19(6):434-438.
8. Saran R., Abbott, Agodoa, Ayanian, Bragg, Gresham, Balkrishnan, Chen, Cope, Eggers, Gillen, Gipson, Hailpern, Hall, Han, He, Herman, Heung, Hutton, Jacobsen, Kalantar-Zadeh, Kovesdy, Lu, Molnar, Morgenster, Nallamothu, Nguyen, O'hare, Obi, Plattner, Pisoni, Port, Rao, Ravel, Rhee, Sakhuja, Schaubel, Selewski, Sim, Song, Streja, Kurella, Tamura, Tentori, White, Woodside, Hirth, Shahinian US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2017, 69(3 Suppl. 1):A7-A8.
9. Albright B., Jordan W. The kidney disease initiative and the division of diabetes translation at the centers for disease control and prevention. Am J Kidney Dis 2009, 53(2):S121-S125.
10. CDCP National chronic kidney disease fact sheet 2017.
11. Bankir Water and kidney physiology. Nutr Today 2013, 48(4):S13-S17.
12. Perrier E.T. Shifting focus: from hydration for performance to hydration for health. Ann Nutr Metab 2017, 70(Suppl. 1):4-12.
13. Clark W.F., Huang S.H., Garg A.X., Gallo K., House A.A., Moist L., et al. The chronic kidney disease water intake trial: protocol of a randomized controlled trial. Can J Kidney Health Dis 2017, 4. 2054358117725106.
14. Sandilands E.A., Dhaun N., Dear J.W., Webb D.J. Measurement of renal function in patients with chronic kidney disease. Br J Clin Pharmacol 2013, 76(4):504-515.
15. Perrier E., Demazières A., Girard N., Pross N., Osbild D., Metzger D., et al. Circadian variation and responsiveness of hydration biomarkers to changes in daily water intake. Eur J Appl Physiol 2013, 113(8):2143-2151.
16. Tack I. Effects of water consumption on kidney function and excretion. Nutr Today 2010, 45(6):S37-S40.
17. Strippoli G.F., Craig J.C., Rochtchina E., Flood V.M., Wang J.J., Mitchell P. Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) 2011, 16(3):326-334.
18. Sontrop J.M., Dixon S.N., Garg A.X., Buendia-Jimenez I., Dohein O., Huang S.H., et al. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data. Am J Nephrol 2013, 37(5):434-442.
19. Capasso G., Saviano C., Ciani F., Lang F., Russo F., De Santo N.G. A decrease in renal medullary tonicity stimulates anion transport in Henle's loop of rat kidneys. Am J Physiol 1998, 274(4 Pt 2):F693-F699.
20. Anastasio P., Cirillo M., Spitali L., Frangiosa A., Pollastro R.M., De Santo N.G. Level of hydration and renal function in healthy humans. Kidney Int 2001, 60(2):748-756.
21. Fenton R.A. Essential role of vasopressin-regulated urea transport processes in the mammalian kidney. Pflüg Arch Eur J Physiol 2009, 458(1):169-177.
22. Bankir L., Bichet D.G., Bouby N. Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?. Am J Physiol Ren Physiol 2010, 299(5):F917-F928.
23. Bankir L., Bichet D.G., Morgenthaler N.G. Vasopressin: physiology, assessment, and osmosensation. J Intern Med 2017, 2:284-297.
24. Bankir L., Bouby N., Ritz E. Vasopressin: a novel target for the prevention and retardation of kidney disease?. Nat Rev Nephrol 2013, 9(4):223-239.
25. Afsar B. Pathophysiology of copeptin in kidney disease and hypertension. Clin Hypertens 2017, 23(1):13.
26. Roussel R., Fezeu L., Marre M., Velho G., Fumeron F., Jungers P., et al. Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J Clin Endocrinol Metab 2014, 99(12):4656-4663.
27. Crowe J., Wesseling C., Solano B.R., Umaña M.P., Ramírez A.R., Kjellstrom T., et al. Heat exposure in sugarcane harvesters in Costa Rica. Am J Ind Med 2013, 56(10):1157-1164.
28. Crowe J., Nilsson M., Kjellstrom T., Cerdas M., Johnson R., Wesseling C. 0401 Repeated pre and post-shift urinalyses show kidney dysfunction among Costa Rican sugarcane cutters exposed to heat stress. Occup Environ Med 2014, 71(Suppl. 1):A51.
29. Wijkström J., Leiva R., Elinder C.-G., Leiva S., Trujillo Z., Trujillo L., et al. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis 2013, 62(5):908-918.
30. Roncal-Jimenez C., Lanaspa M.A., Jensen T., Sanchez-Lozada L.G., Johnson R.J. Mechanisms by which dehydration may lead to chronic kidney disease. Ann Nutr Metab 2015, 66(Suppl. 3):10-13.
31. Nerbass F.B., Pecoits-Filho R., Clark W.F., Sontrop J.M., McIntyre C.W., Moist L. Occupational heat stress and kidney health: from farms to factories. Kidney Int Rep 2017, 10-13.
32. Garcia-Arroyo F.E., Cristobal M., Arellano-Buendia A.S., Osorio H., Tapia E., Soto V., et al. Rehydration with soft drink-like beverages exacerbates dehydration and worsens dehydration-associated renal injury. Am J Physiol Regul Integr Comp Physiol 2016, 311(1):R57-R65.
33. Goldfarb D.S. Increasing prevalence of kidney stones in the United States. Kidney Int 2003, 63(5):1951-1952.
34. Shoag J., Tasian G.E., Goldfarb D.S., Eisner B.H. The new epidemiology of nephrolithiasis. Adv Chronic Kidney Dis 2015, 22(4):273-278.
35. Rule A.D., Bergstralh E.J., Melton L.J., Li X., Weaver A.L., Lieske J.C. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 2009, 4(4):804-811.
36. Paloschi V., Arcidiacono T., Stella P., Rainone F., Terranegra A., Dogliotti E., et al. What do we know after ten years of genetic research into calcium kidney stones?. Giornale italiano di nefrologia: organo ufficiale della Societa italiana di nefrologia 2009, 26(1):64-72.
37. Curhan G.C., Willett W.C., Knight E.L., Stampfer M.J. Dietary factors and the risk of incident kidney stones in younger women: nurses' health study II. Arch Intern Med 2004, 164(8):885-891.
38. Lotan Y., Jiménez I.B., Lenoir-Wijnkoop I., Daudon M., Molinier L., Tack I., et al. Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. J Urol 2013, 189(3):935-939.
39. Pearle M.S., Goldfarb D.S., Assimos D.G., Curhan G., Denu-Ciocca C.J., Matlaga B.R., et al. Medical management of kidney stones: AUA guideline. J Urol 2014, 192(2):316-324.
40. Xu C., Zhang C., Wang X.L., Liu T.Z., Zeng X.T., Li S., et al. Self-fluid management in prevention of kidney stones: a PRISMA-compliant systematic review and dose-response meta-analysis of observational studies. Medicine 2015, 94(27):e1042.
41. Perrier E.T., Buendia-Jimenez I., Vecchio M., Armstrong L.E., Tack I., Klein A. Twenty-four-hour urine osmolality as a physiological index of adequate water intake. Dis Markers 2015, 2015.
42. Ponte B., Pruijm M., Ackermann D., Vuistiner P., Guessous I., Ehret G., et al. Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study. J Am Soc Nephrol 2015, 26(6):1415-1425.
43. Eckford S.D., Keane D.P., Lamond E., Jackson S.R., Abrams P. Hydration monitoring in the prevention of recurrent idiopathic urinary tract infections in pre-menopausal women. BJU Int 1995, 76(1):90-93.
44. Barbosa-Cesnik C., Brown M.B., Buxton M., Zhang L., DeBusscher J., Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis 2011, 52(1):23-30.
45. Türk C., Petík A., Sarica K., Seitz C., Skolarikos A., Straub M., et al. EAU guidelines on interventional treatment for urolithiasis. Eur Urol 2016, 69(3):475-482.
46. Lang F., Guelinckx I., Lemetais G., Melander O. Two liters a day keep the doctor away? Considerations on the pathophysiology of suboptimal fluid intake in the common population. Kidney Blood Press Res 2017, 42(3):483-494.
47. Sontrop J.M., Huang S.H., Garg A.X., Moist L., House A.A., Gallo K., et al. Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial. BMJ Open 2015, 5(11):e008634.
48. Clark W.F., Sontrop J.M., Macnab J.J., Suri R.S., Moist L., Salvadori M., et al. Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol 2011, 6(11):2634-2641.
49. Gomez P., Mariani S.B., Lambert J.-L., Monrozier R. A water intervention program to improve fluid intakes among French women. Nutr Today 2013, 48(4):S40-S42.
50. CDC National diabetes statistics report 2017.
51. Saleem U., Khaleghi M., Morgenthaler N.G., Bergmann A., Struck J., Mosley T.H., et al. Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab 2009, 94(7):2558-2564.
52. Carroll H.A., Davis M.G., Papadaki A. Higher plain water intake is associated with lower type 2 diabetes risk: a cross-sectional study in humans. Nutr Res 2015, 35(10):865-872.
53. Carroll H.A., Betts J.A., Johnson L. An investigation into the relationship between plain water intake and glycated Hb (HbA1c): a sex-stratified, cross-sectional analysis of the UK National Diet and Nutrition Survey (2008-2012). Br J Nutr 2016, 1-11.
54. Enhorning S., Wang T.J., Nilsson P.M., Almgren P., Hedblad B., Berglund G., et al. Plasma copeptin and the risk of diabetes mellitus. Circulation 2010, 121(19):2102-2108.
55. Balanescu S., Kopp P., Gaskill M.B., Morgenthaler N.G., Schindler C., Rutishauser J. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar states. J Clin Endocrinol Metab 2011, 96(4):1046-1052.
56. Schrier R.W., Berl T., Anderson R.J. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979, 236(4):F321-F332.
57. Baylis P.H., Heath D.A. Plasma-arginine-vasopressin response to insulin-induced hypoglycaemia. Lancet 1977, 2(8035):428-430.
58. Koshimizu T.A., Nakamura K., Egashira N., Hiroyama M., Nonoguchi H., Tanoue A. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev 2012, 92(4):1813-1864.
59. Taveau C., Chollet C., Waeckel L., Desposito D., Bichet D.G., Arthus M.F., et al. Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats. Diabetologia 2015, 58(5):1081-1090.
60. Johnson E.C., Bardis C.N., Jansen L.T., Adams J.D., Kirkland T.W., Kavouras S.A. Reduced water intake deteriorates glucose regulation in patients with type 2 diabetes. Nutr Res 2017, 43:25-32.
61. Roussel R., El Boustany R., Bouby N., Potier L., Fumeron F., Mohammedi K., et al. Plasma copeptin, AVP gene variants, and incidence of type 2 diabetes in a cohort from the community. J Clin Endocrinol Metab 2016, 101(6):2432-2439.
62. Lemetais G. Effect of increased water intake on plasma copeptin in health adults. Eur J Nutr 2016.
63. Pan A., Malik V.S., Schulze M.B., Manson J.E., Willett W.C., Hu F.B. Plain-water intake and risk of type 2 diabetes in young and middle-aged women. Am J Clin Nutr 2012, 95(6):1454-1460.
64. Berneis K., Ninnis R., Haussinger D., Keller U. Effects of hyper- and hypoosmolality on whole body protein and glucose kinetics in humans. Am J Physiol 1999, 276(1 Pt 1):E188-E195.
65. Keller U., Szinnai G., Bilz S., Berneis K. Effects of changes in hydration on protein, glucose and lipid metabolism in man: impact on health. Eur J Clin Nutr 2003, 57(Suppl. 2):S69-S74.
66. Flegal K.M., Kruszon-Moran D., Carroll M.D., Fryar C.D., Ogden C.L. Trends in obesity among adults in the United States, 2005 to 2014. J Am Med Assoc 2016, 315(21):2284-2291.
67. Wang Y., Beydoun M.A., Liang L., Caballero B., Kumanyika S.K. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008, 16(10):2323-2330.
68. DiBonaventura M.D., Le Lay A., Fournier J., Kull K., Olmos H.C., Mille I., et al. The burden of obesity in Mexico: prevalence, comorbidities, and associations with quality of life, resource utilization and productivity. Value Health 2015, 18(7):A843.
69. WHO Global health and observatory data: overweight and obesity 2017, Available from:. http://www.who.int/gho/ncd/risk_factors/overweight/en/.
70. GBD Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017.
71. Malik V.S., Schulze M.B., Hu F.B. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr 2006, 84(2):274-288.
72. Ebbeling C.B., Pawlak D.B., Ludwig D.S. Childhood obesity: public-health crisis, common sense cure. Lancet 2002, 360(9331):473-482.
73. Mourao D.M., Bressan J., Campbell W.W., Mattes R.D. Effects of food form on appetite and energy intake in lean and obese young adults. Int J Obes (Lond) 2007, 31(11):1688-1695.
74. Rolls B.J., Kim S., Fedoroff I.C. Effects of drinks sweetened with sucrose or aspartame on hunger, thirst and food intake in men. Physiol Behav 1990, 48(1):19-26.
75. Mattes R.D. Dietary compensation by humans for supplemental energy provided as ethanol or carbohydrate in fluids. Physiol Behav 1996, 59(1):179-187.
76. Harrington S. The role of sugar-sweetened beverage consumption in adolescent obesity: a review of the literature. J Sch Nurs 2008, 24(1):3-12.
77. Armstrong L.E., Barquera S., Duhamel J.F., Hardinsyah R., Haslam D., Lafontan M. Recommendations for healthier hydration: addressing the public health issues of obesity and type 2 diabetes. Clin Obes 2012, 2(5-6):115-124.
78. Schwarz J.M., Noworolski S.M., Wen M.J., Dyachenko A., Prior J.L., Weinberg M.E., et al. Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat. J Clin Endocrinol Metab 2015, 100(6):2434-2442.
79. Stanhope K.L., Schwarz J.M., Keim N.L., Griffen S.C., Bremer A.A., Graham J.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Investig 2009, 119(5):1322-1334.
80. Malik V.S., Pan A., Willett W.C., Hu F.B. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr 2013, 98(4):1084-1102.
81. Ebbeling C.B., Feldman H.A., Chomitz V.R., Antonelli T.A., Gortmaker S.L., Osganian S.K., et al. A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med 2012, 367(15):1407-1416.
82. Muckelbauer R., Sarganas G., Gruneis A., Muller-Nordhorn J. Association between water consumption and body weight outcomes: a systematic review. Am J Clin Nutr 2013, 98(2):282-299.
83. Chang T., Ravi N., Plegue M.A., Sonneville K.R., Davis M.M. Inadequate hydration, BMI, and obesity among US adults: NHANES 2009-2012. Ann Fam Med 2016, 14(4):320-324.
84. Bilz S., Ninnis R., Keller U. Effects of hypoosmolality on whole-body lipolysis in man. Metabolism 1999, 48(4):472-476.
85. Karlsson C., Lindell K., Ottosson M., Sjostrom L., Carlsson B., Carlsson L.M. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998, 83(11):3925-3929.
86. Schling P., Mallow H., Trindl A., Loffler G. Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord 1999, 23(4):336-341.
87. Engeli S., Gorzelniak K., Kreutz R., Runkel N., Distler A., Sharma A.M. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999, 17(4):555-560.
88. Kouyama R., Suganami T., Nishida J., Tanaka M., Toyoda T., Kiso M., et al. Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 2005, 146(8):3481-3489.
89. Massiera F., Seydoux J., Geloen A., Quignard-Boulange A., Turban S., Saint-Marc P., et al. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 2001, 142(12):5220-5225.
90. Weisinger R.S., Stanley T.K., Begg D.P., Weisinger H.S., Spark K.J., Jois M. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiol Behav 2009, 98(1-2):192-197.
91. Santos E.L., de Picoli Souza K., Guimaraes P.B., Reis F.C., Silva S.M., Costa-Neto C.M., et al. Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats. Int Immunopharmacol 2008, 8(2):247-253.
92. Takahashi N., Li F., Hua K., Deng J., Wang C.H., Bowers R.R., et al. Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab 2007, 6(6):506-512.
93. Kohlstedt K., Gershome C., Trouvain C., Hofmann W.K., Fichtlscherer S., Fleming I. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade. Mol Pharmacol 2009, 75(3):685-692.
94. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004, 10(5):524-529.
95. Masaki T., Chiba S., Yasuda T., Tsubone T., Kakuma T., Shimomura I., et al. Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice. Diabetes 2003, 52(9):2266-2273.
96. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8(11):1288-1295.
97. Ruskoaho H., Lang R.E., Toth M., Ganten D., Unger T. Release and regulation of atrial natriuretic peptide (ANP). Eur Heart J 1987, 8(Suppl. B):99-109.
98. Bordicchia M., Liu D., Amri E.Z., Ailhaud G., Dessi-Fulgheri P., Zhang C., et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Investig 2012, 122(3):1022-1036.
99. Wang T.J. The natriuretic peptides and fat metabolism. N Engl J Med 2012, 367(4):377-378.
100. Collins S., Bordicchia M. Heart hormones fueling a fire in fat. Adipocyte 2013, 2(2):104-108.
101. WHO The top 10 causes of death 2017, Available from:. http://www.who.int/mediacentre/factsheets/fs310/en/.
102. Chan J., Knutsen S.F., Blix G.G., Lee J.W., Fraser G.E. Water, other fluids, and fatal coronary heart disease: the Adventist Health Study. Am J Epidemiol 2002, 155(9):827-833.
103. Dmitrieva N.I., Burg M.B. Elevated sodium and dehydration stimulate inflammatory signaling in endothelial cells and promote atherosclerosis. PLoS One 2015, 10(6):e0128870.
104. Lang F., Ritz E., Voelkl J., Alesutan I. Vascular calcification-is aldosterone a culprit?. Nephrol Dial Transplant 2013.
105. Thornton S.N. Angiotensin inhibition and longevity: a question of hydration. Pflug Arch Eur J Physiol 2011, 461(3):317-324.
106. Thornton S.N. Diabetes and hypertension, as well as obesity and Alzheimer's disease, are linked to hypohydration-induced lower brain volume. Front Aging Neurosci 2014, 6:279.
107. Koenig W., Sund M., Filipiak B., Döring A., Löwel H., Ernst E. Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arterioscler Thromb Vasc Biol 1998, 18(5):768-772.
108. Yasaka M., Yamaguchi T., Oita J., Sawada T., Shichiri M., Omae T. Clinical features of recurrent embolization in acute cardioembolic stroke. Stroke 1993, 24(11):1681-1685.
109. Tonstad S., Klemsdal T.O., Landaas S., Høieggen A. No effect of increased water intake on blood viscosity and cardiovascular risk factors. Br J Nutr 2006, 96(6):993-996.
110. King M.A., Clanton T.L., Laitano O. Hyperthermia, dehydration, and osmotic stress: unconventional sources of exercise-induced reactive oxygen species. Am J Physiol Regul Integr Comp Physiol 2016, 310(2):R105-R114.
111. Higashi Y., Noma K., Yoshizumi M., Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009, 73(3):411-418.
112. Arnaoutis G., Kavouras S.A., Stratakis N., Likka M., Mitrakou A., Papamichael C., et al. The effect of hypohydration on endothelial function in young healthy adults. Eur J Nutr 2017, 56(3):1211-1217.
113. Karatzi K., Papamichael C., Karatzis E., Papaioannou T.G., Stamatelopoulos K., Zakopoulos N.A., et al. Acute smoke-induced endothelial dysfunction is more prolonged in smokers than in non-smokers. Int J Cardiol 2007, 120(3):404-406.
114. Hoekstra F.A., Golovina E.A., Buitink J. Mechanisms of plant desiccation tolerance. Trends Plant Sci 2001, 6(9):431-438.
115. Hansen J.M., Go Y.M., Jones D.P. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol 2006, 46:215-234.
116. Paik I.Y., Jeong M.H., Jin H.E., Kim Y.I., Suh A.R., Cho S.Y., et al. Fluid replacement following dehydration reduces oxidative stress during recovery. Biochem Biophys Res Commun 2009, 383(1):103-107.
117. Preedy Oxidative stress and dietary antioxidants [Internet] 2013, Elsevier Science.
118. Nathan C., Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000, 97(16):8841-8848.
119. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39(1):44-84.
120. Li L., Galligan J.J., Fink G.D., Chen A.F. Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension. Hypertension 2003, 41(3 Pt 2):663-668.
121. Faraco G., Wijasa T.S., Park L., Moore J., Anrather J., Iadecola C. Water deprivation induces neurovascular and cognitive dysfunction through vasopressin-induced oxidative stress. J Cereb Blood Flow Metab 2014, 34(5):852-860.
122. Ishikawa Renoprotective effect of vasopressin antagonist tolvaptan in Dahl rats with end-stage heart failure. N Engl J Med 2012, 345:851-860.
123. Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015, 136(5):E359-E386.
124. Braver D.J., Modan M., Chetrit A., Lusky A., Braf Z. Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer. J Natl Cancer Inst 1987, 78(3):437-440.
125. Radosavljevic V., Jankovic S., Marinkovic J., Djokic M. Fluid intake and bladder cancer. A case control study. Neoplasma 2003, 50(3):234-238.
126. Bruemmer B., White E., Vaughan T.L., Cheney C.L. Fluid intake and the incidence of bladder cancer among middle-aged men and women in a three-county area of western Washington. Nutr Cancer 1997, 29(2):163-168.
127. Jensen O.M., Wahrendorf J., Knudsen J.B., Sorensen B.L. The Copenhagen case-control study of bladder cancer. II. Effect of coffee and other beverages. Int J Cancer 1986, 37(5):651-657.
128. Claude J., Kunze E., Frentzel-Beyme R., Paczkowski K., Schneider J., Schubert H. Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 1986, 124(4):578-589.
129. Slattery M.L., West D.W., Robison L.M. Fluid intake and bladder cancer in Utah. Int J Cancer 1988, 42(1):17-22.
130. Cantor K.P., Hoover R., Hartge P., Mason T.J., Silverman D.T., Altman R., et al. Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst 1987, 79(6):1269-1279.
131. Michaud D.S., Spiegelman D., Clinton S.K., Rimm E.B., Curhan G.C., Willett W.C., et al. Fluid intake and the risk of bladder cancer in men. N Engl J Med 1999, 340(18):1390-1397.